Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Genomic analysis of metastatic rhabdomyosarcoma masquerading as acute leukemia.

Pasvolsky O, Heiman L, Popovtzer A, Zimra Y, Rabizadeh E, Barshack I, Mardoukh C, Raanani P, Rozovski U.

Pathol Res Pract. 2019 Dec 2:152779. doi: 10.1016/j.prp.2019.152779. [Epub ahead of print]

PMID:
31813602
2.

Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study.

Shimony S, Horowitz N, Ribakovsky E, Rozovski U, Avigdor A, Zloto K, Berger T, Avivi I, Perry C, Abadi U, Raanani P, Gafter-Gvili A, Gurion R.

Hematol Oncol. 2019 Oct 31. doi: 10.1002/hon.2691. [Epub ahead of print]

PMID:
31674027
3.

STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage.

Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger JA, Bose P, Thompson PA, Jain N, Wierda WG, Uziel O, Keating MJ, Estrov Z.

J Immunol. 2019 Dec 1;203(11):3078-3085. doi: 10.4049/jimmunol.1900389. Epub 2019 Oct 23.

PMID:
31645416
4.

Indications for genetic testing leading to termination of pregnancy.

Svirsky R, Pekar-Zlotin M, Rozovski U, Maymon R.

Arch Gynecol Obstet. 2019 Nov;300(5):1221-1225. doi: 10.1007/s00404-019-05289-4. Epub 2019 Sep 16.

PMID:
31529364
5.

Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control study.

Berger T, Rozovski U, Moshe Y, Yaari S, Frisch A, Hellmann I, Apel A, Aviram A, Koren-Michowitz M, Yeshurun M, Ram R, Raanani P, Ofran Y, Wolach O.

Ann Hematol. 2019 Dec;98(12):2711-2717. doi: 10.1007/s00277-019-03795-8. Epub 2019 Sep 11.

PMID:
31512015
6.

Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma.

Abadi U, Peled L, Gurion R, Rotman-Pikielny P, Raanani P, Ellis MH, Rozovski U.

Leuk Lymphoma. 2019 Dec;60(12):2922-2926. doi: 10.1080/10428194.2019.1620946. Epub 2019 Jun 6.

PMID:
31167584
7.

The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells.

Shalem-Cohavi N, Beery E, Nordenberg J, Rozovski U, Raanani P, Lahav M, Uziel O.

Int J Mol Sci. 2019 May 21;20(10). pii: E2509. doi: 10.3390/ijms20102509.

8.

Anthracycline-Induced Cardiotoxicity in Acute Myeloid Leukemia Patients Who Undergo Allogeneic Hematopoietic Stem Cell Transplantation.

Pasvolsky O, Morelli O, Rozovski U, Vaturi M, Wolach O, Amitai I, Vaxman I, Ratzon R, Yeshurun M, Kornowski R, Iakobishvilli Z, Raanani P.

Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e343-e348. doi: 10.1016/j.clml.2019.03.007. Epub 2019 Mar 11.

PMID:
30948329
9.

Characteristics and outcomes of young adults with Philadelphia-negative myeloproliferative neoplasms.

Barzilai M, Kirgner I, Avivi I, Ellis M, Dally N, Rozovski U, Lavi N.

Eur J Haematol. 2019 Jun;102(6):504-508. doi: 10.1111/ejh.13232. Epub 2019 Apr 25.

PMID:
30941804
10.

Human herpes virus 6 reactivation following autologous hematopoietic cell transplantation - a single-center experience.

Shargian-Alon L, Yahav D, Rozovski U, Dovrat S, Amitai I, Sela-Navon M, Pasvolsky O, Raanani P, Yeshurun M.

Leuk Lymphoma. 2019 Sep;60(9):2230-2236. doi: 10.1080/10428194.2019.1576869. Epub 2019 Feb 18.

PMID:
30773083
11.

Impaired lymphocyte reconstitution after autologous transplant is associated with apoptosis of CD8+ T cells and adverse clinical outcome.

Rozovski U, Naparstek E, Frank S, Fourman A, Zigman-Hoffman E, Bleiberg M, Yeshurun M, Trestman S, Tartakovsky B.

Leuk Lymphoma. 2019 Sep;60(9):2264-2270. doi: 10.1080/10428194.2018.1563696. Epub 2019 Jan 18.

PMID:
30656985
12.

Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.

Shargian-Alon L, Raanani P, Rozovski U, Siegal T, Yust-Katz S, Yeshurun M.

Acta Haematol. 2019;141(1):19-22. doi: 10.1159/000494423. Epub 2018 Nov 15.

PMID:
30439710
13.

The Effect of Ethanol on Telomere Dynamics and Regulation in Human Cells.

Harpaz T, Abumock H, Beery E, Edel Y, Lahav M, Rozovski U, Uziel O.

Cells. 2018 Oct 15;7(10). pii: E169. doi: 10.3390/cells7100169.

14.

STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells.

Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger J, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z.

Oncotarget. 2018 Sep 14;9(72):33710-33718. doi: 10.18632/oncotarget.26110. eCollection 2018 Sep 14.

15.

Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?

Rozovski U, Keating MJ, Estrov Z.

Acta Haematol. 2018;140(1):51-54. doi: 10.1159/000491382. Epub 2018 Aug 16. Review.

16.

Real-life Experience With Ponatinib in Chronic Myeloid Leukemia: A Multicenter Observational Study.

Shacham-Abulafia A, Raanani P, Lavie D, Volchek Y, Ram R, Helman I, Shargian L, Gourevitch A, Chubar E, Ratzon R, Rozovski U.

Clin Lymphoma Myeloma Leuk. 2018 Jul;18(7):e295-e301. doi: 10.1016/j.clml.2018.05.002. Epub 2018 May 7.

PMID:
29773429
17.

STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells.

Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger J, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z.

Oncotarget. 2018 Apr 20;9(30):21268-21280. doi: 10.18632/oncotarget.25066. eCollection 2018 Apr 20.

18.

MYC protein expression is an important prognostic factor in acute myeloid leukemia.

Ohanian M, Rozovski U, Kanagal-Shamanna R, Abruzzo LV, Loghavi S, Kadia T, Futreal A, Bhalla K, Zuo Z, Huh YO, Post SM, Ruvolo P, Garcia-Manero G, Andreeff M, Kornblau S, Borthakur G, Hu P, Medeiros LJ, Takahashi K, Hornbaker MJ, Zhang J, Nogueras-González GM, Huang X, Verstovsek S, Estrov Z, Pierce S, Ravandi F, Kantarjian HM, Bueso-Ramos CE, Cortes JE.

Leuk Lymphoma. 2019 Jan;60(1):37-48. doi: 10.1080/10428194.2018.1464158. Epub 2018 May 9.

PMID:
29741984
19.

The genetic and clinical outcome of isolated fetal muscular ventricular septal defect (VSD).

Svirsky R, Brabbing-Goldstein D, Rozovski U, Kapusta L, Reches A, Yaron Y.

J Matern Fetal Neonatal Med. 2019 Sep;32(17):2837-2841. doi: 10.1080/14767058.2018.1449829. Epub 2018 Mar 20.

PMID:
29510647
20.

Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia.

Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger J, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z.

Leuk Lymphoma. 2018 Nov;59(11):2686-2691. doi: 10.1080/10428194.2018.1439167. Epub 2018 Feb 21.

Supplemental Content

Loading ...
Support Center